Juvenile Idiopathic ArthritisNCT00415935
PRINTO (the Paediatric Rheumatology International Trials Organisation)
An observational study of Juvenile Idiopathic Arthritis, run by Institute of Child Health at 1 site in United Kingdom.
Trial summary
A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months Read more about this study
- Who is it for?
- Ages Up to 16 years
- Conditions the study is for
- Juvenile Idiopathic Arthritis
- What is being tested?
- methotrexate
- How many people
- Not given
- Where
- 1 siteUnited Kingdom
- Study dates
- Start not givento Dec 2006
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 16 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Any child with JIA who has gone into remission using methotrexate
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
Lucy Wedderburn, Dr contact
United Kingdom1 site, 1 recruiting
- Recruiting
Rheumatology ICH
London, WC1N 1EH
Lucy Wedderburn, Dr, l.wedderburn@ich.ucl.ac.uk
About this study
A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months
- Conditions
- Juvenile Idiopathic Arthritis
- Being tested
- methotrexate
- Medical subject headings
- Arthritis, Juvenile
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
methotrexateDrug
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Dec 2006 (estimated)
- Study completionDec 2006
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Juvenile Idiopathic ArthritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Defined population
- Time perspective
- Prospective
Sponsor and investigators
- Lead sponsor
- Institute of Child Health
- Sponsor type
- University, hospital or other
- Investigators
- Lucy Wedderburn, Dr, Principal investigator, Institute Of Child Health and Great Ormond Street Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00415935
- Sponsor's protocol ID
- 04RU01
- Status last verified
- Dec 2006
- First submitted
- 22 Dec 2006
- Last updated
- 25 Dec 2006
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Dec 2006. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- PRINTO (the Paediatric Rheumatology International Trials Organisation)
- ClinicalTrials.gov ID
- NCT00415935
- Acronym / sponsor ID
- 04RU01
- Conditions
- Juvenile Idiopathic Arthritis
- Study type
- Observational
- Recruitment status
- Unknown status
- Lead sponsor
- Institute of Child HealthUniversity, hospital or other
- Study completion
- Dec 2006
- First posted
- 25 Dec 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months
Study design
- Observational model
- Defined population
- Time perspective
- Prospective
Who may qualify
- Ages
- Up to 16 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- Any child with JIA who has gone into remission using methotrexate
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| methotrexate | Drug | – |
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Dec 2006.
Related trials for Juvenile Idiopathic Arthritis
RecruitingPhase 3
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis
Recruiting
The Use of Infrared Cameras for Detecting Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis, Infrared Thermography
Not yet recruitingPhase 4
Withdrawal Versus Continued TNF Inhibitor Monotherapy Treatment in Children With Inactive Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis (JIA)
RecruitingObservational study
Tofacitinib in Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis (JIA)
RecruitingPhase 3
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Enthesitis-related Arthritis, Juvenile Psoriatic Arthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lucy Wedderburn, Dr contact
Lucy Wedderburn, Dr principal investigator
Institute Of Child Health and Great Ormond Street Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Juvenile Idiopathic Arthritis, run by Institute of Child Health at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 25 Dec 2006. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Lucy Wedderburn, Dr (l.wedderburn@ich.ucl.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Dec 2006.